HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+5.82%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$123M
AUM Growth
+$123M
(-27%)
Cap. Flow
-$43.1M
Cap. Flow
% of AUM
-35.11%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
142
New
37
Increased
19
Reduced
19
Closed
34
Top Buys
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
$3.46M |
| 2 |
Albertsons Companies
ACI
|
$3.2M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$3.17M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$3.14M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
$2.61M |
Top Sells
| 1 |
Dell
DELL
|
$14.3M |
| 2 |
Mastercard
MA
|
$12.9M |
| 3 |
Fiserv
FI
|
$9.07M |
| 4 |
Visa
V
|
$8.83M |
| 5 |
MSDAU
MSD Acquisition Corp. Unit
MSDAU
|
$5.05M |
Sector Composition
| 1 | Healthcare | 67.14% |
| 2 | Technology | 10.92% |
| 3 | Consumer Discretionary | 4.92% |
| 4 | Financials | 4.39% |
| 5 | Communication Services | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Incyte
INCY
$17B
| $786K | 0.64% |
10,879
| – | – |
|
52
Crinetics Pharmaceuticals
CRNX
$3.26B
| $775K | 0.63% |
48,245
-45,648
| -49% | -$733K |
|
53
Biogen
BIIB
$20.5B
| $763K | 0.62% |
2,743
| – | – |
|
54
Kymera Therapeutics
KYMR
$3.1B
| $756K | 0.62% |
+25,530
| New | +$756K |
|
|
55
Visa
V
$681B
| $753K | 0.61% |
3,340
-39,175
| -92% | -$8.83M |
|
|
AMRN
56
Amarin Corp
AMRN
$311M
| $751K | 0.61% |
25,034
| – | – |
|
57
Vaxcyte
PCVX
$4.17B
| $735K | 0.6% |
19,606
| – | – |
|
58
United Therapeutics
UTHR
$17.7B
| $718K | 0.58% |
3,204
| – | – |
|
59
Akero Therapeutics
AKRO
$3.65B
| $713K | 0.58% |
18,629
| – | – |
|
60
Prothena Corp
PRTA
$452M
| $706K | 0.58% |
14,572
| – | – |
|
|
ALPN
61
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $697K | 0.57% |
+90,287
| New | +$697K |
|
62
Amazon
AMZN
$2.41T
| $679K | 0.55% |
6,570
+1,370
| +26% | +$142K |
|
63
Madrigal Pharmaceuticals
MDGL
$9.7B
| $677K | 0.55% |
+2,796
| New | +$677K |
|
64
Immunocore
IMCR
$1.78B
| $652K | 0.53% |
13,194
| – | – |
|
|
65
Fiserv
FI
$74.3B
| $642K | 0.52% |
5,682
-80,244
| -93% | -$9.07M |
|
66
Rhythm Pharmaceuticals
RYTM
$6.75B
| $633K | 0.52% |
35,478
| – | – |
|
|
67
Mastercard
MA
$536B
| $607K | 0.49% |
1,670
-35,524
| -96% | -$12.9M |
|
|
MRTX
68
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $585K | 0.48% |
15,738
+4,035
| +34% | +$150K |
|
69
AnaptysBio
ANAB
$630M
| $549K | 0.45% |
25,219
+11,215
| +80% | +$244K |
|
70
Intuit
INTU
$187B
| $544K | 0.44% |
1,220
+600
| +97% | +$267K |
|
71
Syndax Pharmaceuticals
SNDX
$1.39B
| $541K | 0.44% |
25,604
+6,943
| +37% | +$147K |
|
72
Arvinas
ARVN
$580M
| $524K | 0.43% |
19,197
+3,203
| +20% | +$87.5K |
|
|
BLU
73
DELISTED
BELLUS Health Inc.
BLU
| $492K | 0.4% |
68,292
-23,201
| -25% | -$167K |
|
|
EDR
74
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $458K | 0.37% |
+19,160
| New | +$458K |
|
|
SWTX
75
DELISTED
SpringWorks Therapeutics
SWTX
| $454K | 0.37% |
17,647
-17,156
| -49% | -$442K |
|